[Therapy of nonseptic cardiogenic circulatory failure].
Griebenow
R
R
Medizinische Universitätsklinik II, Medizinische Klinik Merheim, Köln.
D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002395:Catecholamines / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D002317:Cardiovascular Agents; D002395:Catecholamines
Therapie des nichtseptischen kardiogenen Kreislaufversagens.